Search | Pikumil

Rina Choudhary added blog Other
2026-08-10 19:30:55 -

Circular RNA Therapeutics Market Size and Revenue Forecast to 2033
According to the latest report published by Data Bridge Market Research, the Circular RNA Therapeutics Market The global Circular RNA Therapeutics market size was valued at USD 784 Million in 2025and is expected to reach USD 4188.13 Million by 2033, at a CAGR of 23.30% during the forecast period To impart a supreme quality to this persuasive Circular RNA...

0 Comments 0 Shares 2K Views 0 Reviews

Please log in to like, share and comment!
Rina Choudhary added blog Other
2026-06-15 08:25:58 -

Circular RNA Therapeutics Market Size, Industry Trends, and Growth Forecast to 2033
According to the latest report published by Data Bridge Market Research, the Circular RNA Therapeutics Market The global Circular RNA Therapeutics market size was valued at USD 784 Million in 2025 and is expected to reach USD 4188.13 Million by 2033, at a CAGR of 23.30% during the forecast period To impart a supreme quality to this persuasive Circular RNA...

0 Comments 0 Shares 11K Views 0 Reviews

Please log in to like, share and comment!
Rina Choudhary added blog Other
2026-08-03 14:32:04 -

Lipoprotein(a)-Targeted RNA Therapeutics Market Size and Revenue Forecast to 2033
According to the latest report published by Data Bridge Market Research, the Lipoprotein(a)-Targeted RNA Therapeutics Market The Lipoprotein(a)-Targeted RNA Therapeutics Market was valued at USD 1.68 billion in 2025 and is projected to reach USD 7.17 billion by 2033, growing at a CAGR of 19.90% from 2026 to 2033. The market is witnessing strong growth driven by...

0 Comments 0 Shares 1K Views 0 Reviews

Please log in to like, share and comment!
Ajay Sukla added blog Health
2026-03-30 10:20:24 -

RdRp Inhibitor Market to Reach USD 521.68 Million by 2028 | CAGR 8.2%
According to a newly published market research report by 24LifeSciences, global RdRp inhibitor market was valued at USD 352.14 million in 2023 and is projected to reach USD 521.68 million by 2028, growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period 2024-2028. RNA-dependent RNA polymerase (RdRp) inhibitors represent a critical antiviral therapy class that prevents...

0 Comments 0 Shares 1K Views 0 Reviews

Please log in to like, share and comment!